Share on

Europe Stem Cell Therapy Market Research Report – Segmented By Type, Application, Cell Source, End-Users and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends and Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 11500
Pages: 90
Formats: report pdf report excel report power bi report ppt

Europe Stem Cell Therapy Market Size (2023 to 2028)

The size of the European stem cell therapy market is estimated to register a CAGR of 10.46% between 2023 to 2028.

The European stem cell therapy market is expected to be primarily driven by the factors such as a growing number of biomedical research efforts and a growing focus on the treatment for neurological disorders. Evolving induced pluripotent stem cell lines in the European region are contributing to the regional market growth. Also, rising socio-ethical issues involved with embryonic stem cells and adoption of iPSCs as alternatives are most likely to evolve the European stem cell therapy market growth. Moreover, European regional companies are developing innovative therapeutic technologies that can boost market growth. Due to the advancement of contemporary health research, stem cells play an important role in researching disease prevalence, drug discovery, and the development of innovative regenerative medicines.

On the other hand, private and government organizations boosting investment and funding for better hospital infrastructures encourages the stem cell therapy market. Personalized drugs are becoming increasingly common, which is fuelling the European stem cell therapy market growth. Researchers are designing innovative sourcing approaches that can also be used to develop personalized drugs. Companies are undertaking fundamental science and preclinical studies to assess stem cells' regenerative capability in the treatment of personalized disorders. For example, iPSC therapies are created by taking a tiny amount of a patient's blood or skin cells and reprogramming them to shape new cells and tissue for transplant. As a result, future customized therapies can be produced by the use of these cells.

However, stringent government regulations on stem cell therapies are expected to restrain the European stem cell therapy market growth. Also, a lack of awareness about stem cell therapy in underdeveloped countries is considered to be one of the growth restrains factors for the market growth. Technical constraints associated with production scale-up and a scarcity of trained practitioners are regarded as hindrances to market growth. Furthermore, the difficulties of collecting and storing somatic cell stem cells limit the European stem cell therapy market growth.

Impact of COVID-19 on the Europe Stem Cell Therapy Market:

The global pandemic COVID-19 had affected the market sector in different ways. The European regional market had negatively impacted due to the limited exchange activities in the region. Europe had implemented the lockdown to control disease transmission. The prohibition on transportation had disrupted the supply chain.

However, post to the uplift of lockdown, the market has recorded significant growth due to the rising demand for personalized treatments. Companies are focusing on developing therapies for reducing different stress associated with COVID-19.  In October, NoveCite and Novellus Therapeutics Limited have formed a collaboration to produce and commercialize NoveCite iPSCs to treat COVID-19-associated Acute Respiratory Distress Syndrome (ARDS).

This research report on the Europe stem cell therapy market has been segmented and sub-segmented based on the following categories.

 By Type:

  • Allogeneic
  • Autologous

By Application:

  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cardiovascular Diseases
  • Surgeries
  • Gastrointestinal Diseases
  • Other Applications

By Cell Source:

  • Adipose Tissue-Derived Mesenchymal Stem Cells
  • Bone Marrow-Derived Mesenchymal Stem Cells
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

By End User:

  • Hospitals
  • Clinics

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Stem cell research is one of the most promising fields of medicine in the twenty-first century, with the potential to revolutionize the way we treat disorders such as degenerative diseases, for which there are actually few effective drugs. The European stem cell market is one of the most rapidly growing markets. The European regional stem cell therapy market recorded significant growth in 2022.

In the regional stem cell therapy market, the United Kingdom witnessed significant growth over the forecast period. The market growth is attributed as Stem cell therapies are gaining momentum as a potential cure for diseases such as Parkinson's disease, Alzheimer's disease, cancer, and diabetes, which affect a significant proportion of the population in the United Kingdom. As per the Global Cancer Observatory, more than 446,900 new cancer cases were registered in the United Kingdom in 2018. Furthermore, cancers such as breast, prostate, eye, and lung are among the most commonly diagnosed cancers in the country.

Germany is one of the promising countries in Europe, with a rapidly growing stem cell therapy market growth over the forecast period. The growing geriatric population, adoption of innovative therapeutic technologies, and supportive government funds for the healthcare infrastructure are most likely to encourage the stem cell therapy market growth in the country.

KEY MARKET PLAYERS:

Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate SRL, JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., and Allosource are a few of the companies playing a promising role in the European stem cell therapy market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample